Prolactin as an autocrine/paracrine growth factor in human cancer

Trends in Endocrinology and Metabolism

Volumn 13, Issue 6, 2002, Pages 245-250

  Ben Jonathan, Nira ^a   Liby, Karen ^a   McFarland, Molly ^a   Zinger, Michael ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; CYTOKINE RECEPTOR; GROWTH FACTOR; MEMBRANE RECEPTOR; PROLACTIN; PROLACTIN RECEPTOR; GROWTH PROMOTOR;

AUTOCRINE EFFECT; CANCER; CANCER CELL CULTURE; CANCER INHIBITION; CARCINOGENESIS; CELL GROWTH; CELL SURVIVAL; HORMONE RECEPTOR INTERACTION; HUMAN; HUMAN CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROLACTIN SYNTHESIS; PROTEIN EXPRESSION; RECEPTOR BLOCKING; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; APOPTOSIS; BREAST TUMOR; CELL DIVISION; FEMALE; HYPOPHYSIS; MALE; METABOLISM; NEOPLASM; PATHOLOGY; PHYSIOLOGY; PROSTATE TUMOR;

ANIMALS; APOPTOSIS; BREAST NEOPLASMS; CELL DIVISION; FEMALE; GROWTH SUBSTANCES; HUMANS; MALE; NEOPLASMS; PITUITARY GLAND; PROLACTIN; PROSTATIC NEOPLASMS; RECEPTORS, PROLACTIN; SIGNAL TRANSDUCTION;

EID: 0036673766     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(02)00603-3     Document Type: Review

References (71)

1. Sinha, Y.N. (1995) Structural variants of prolactin: occurrence and physiological significance. Endocr. Rev. 16, 354-369
2. Xu, X. et al. (2001) A molecular mimic of phosphorylated prolactin markedly reduced tumor incidence and size when DU145 human prostate cancer cells were grown in nude mice. Cancer Res. 61, 6098-6104
3. Struman, I. et al. (1999) Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: an efficient mechanism for the regulation of angiogenesis. Proc. Natl. Acad. Sci. U. S. A. 96, 1246-1251
4. Khurana, S. et al. (1999) Heparin-binding property of human prolactin: a novel aspect of prolactin biology. Endocrinology 140, 1026-1029
5. Ben-Jonathan, N. et al. (1996) Extrapituitary prolactin: distribution, regulation, functions and clinical aspects. Endocr. Rev. 17, 639-669
6. Ollivier-Bousquet, M. et al. (1993) Prolactin transit through mammary epithelial cells and appearance in milk. Endocr. Regul. 27, 115-124
7. Rycyzyn, M.A. et al. (2000) Role of cyclophilin B in prolactin signal transduction and nuclear retrotranslocation. Mol. Endocrinol. 14, 1175-1186
8. Bole-Feysot, C. et al. (1998) Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr. Rev. 19, 225-268
9. Kline, J.B. et al. (1999) Functional characterization of the intermediate isoform of the human prolactin receptor. J. Biol. Chem. 274, 35461-35468
10. Hu, Z.Z. et al. (2001) Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11. J. Biol. Chem. 276, 41086-41094
11. Dannies, P.S. (2001)A serum prolactin-binding protein: implications for growth hormone. Trends Endocrinol. Metab. 12, 427-428
12. Fuh, G. and Wells, J.A. (1995) Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. J. Biol. Chem. 720, 13133-13137
13. Vonderhaar, B.K. (1998) Prolactin: the forgotten hormone of human breast cancer. Pharmacol. Ther. 79, 169-178
14. Ben-Jonathan, N. and Hnasko, R.M. (2001) Dopamine as a prolactin inhibitor. Endocr. Rev. 22, 724-763
15. Gellersen, B. et al. (1994) Nonpituitary human prolactin gene transcription is independent of Pit-1 and differentially controlled in lymphocytes and in endometrial stroma. Mol. Endocrinol. 8, 356-373
16. Pohnke, Y. et al. (1999) CCAAT/enhancer-binding proteins are mediators in the protein kinase A-dependent activation of the decidual prolactin promoter. J. Biol. Chem. 274, 24808-24818
17. Flint, D.J. and Knight, C.H. (1997) Interactions of prolactin and growth hormone (GH) in the regulation of mammary gland function and epithelial cell survival. J. Mammary Gland Biol. Neoplasia 2, 41-48
18. Leff, M.A. et al. (1996) Rapid modulation of the apoptosis regulatory genes, bcl-2 and bax by prolactin in rat Nb2 lymphoma cells. Endocrinology 137, 5456-5462
19. DeVito, W.J. et al. (1993) Prolactin-stimulated mitogenesis of cultured astrocytes is mediated by a protein kinase C-dependent mechanism. J. Neurochem. 60, 835-842
20. Grimley, P.M. et al. (1999) Stat5a and Stat5b: fraternal twins of signal transduction and transcriptional activation. Cytokine Growth Factor Rev. 10, 131-157
21. Yamauchi, T. et al. (2000) Constitutive tyrosine phosphorylation of ErbB-2 via Jak2 by autocrine secretion of prolactin in human breast cancer. J. Biol. Chem. 275, 33937-33944
22. Favy, D.A. et al. (1999) Prolactin-dependent upregulation of BRCA1 expression in human breast cancer cell lines. Biochem. Biophys. Res. Commun. 258, 284-291
23. Nandi, S. et al. (1995) Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. Proc. Natl. Acad. Sci. U. S. A. 92, 3650-3657
24. Wennbo, H. et al. (1997) Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J. Clin. Invest. 100, 2744-2751
25. Hankinson, S.E. et al. (1999) Plasma prolactin levels and subsequent risk ofbreast cancer in postmenopausal women. J. Natl. Cancer Inst. 91, 629-634
26. Manni, A. et al. (1989) Endocrine effects of combined somatostatin analog and bromocriptine therapy in women with advanced breast cancer. Breast Cancer Res. Treat. 14,289-298
27. Llovera, M. et al. (2000) Human prolactin (hPRL) antagonists inhibit hPRL-activated signaling pathways involved in breast cancer cell proliferation. Oncogene 19, 4695-4705
28. Touraine, P. et al. (1998) Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. J. Clin. Endocrinol. Metab. 83, 667-674
29. Peirce, S.K. et al. (2001) Quantification of prolactin receptor mRNA in multiple human tissues and cancer cell lines by real time RT-PCR. J. Endocrinol. 171, R1-R4
30. Shaw-Bruha, C.M. et al. (1997) Expression of the prolactin gene in normal and neoplastic human breast tissues and human mammary cell lines: promoter usage and alternative mRNA splicing. Breast Cancer Res. Treat. 44, 243-253
31. Ginsburg, E. and Vonderhaar, B.K. (1995) Prolactin synthesis and secretion by human breast cancer cells. Cancer Res. 55, 2591-2595
32. Chen, W.Y. et al. (1999) A human prolactin antagonist, hPRL-G129R, inhibits breast cancer cell proliferation through induction of apoptosis. Clin. Cancer Res. 5, 3583-3593
33. Chen, N.Y. et al. (2002) In vivo studies of the anti-tumor effects of a human prolactin antagonist, hPRL-G129R. Int. J. Oncol. 20, 813-818
34. Canbay, E. et al. (1997) Prolactin stimulates the JAK2 and focal adhesion kinase pathways in human breast carcinoma T47-D cells. Biochem. J. 324, 231-236
35. Maus, M.V. et al. (1999) Prolactin as a chemoattractant for human breast carcinoma. Endocrinology 140, 5447-5450
36. Reiter, E. et al. (1999) Effects of pituitary hormones on the prostate. Prostate 38, 159-165
37. Lane, K.E. et al. (1997) Suppression of testosterone and estradiol-17β-induced dysplasia in the dorsolateral prostate of Noble rats by bromocriptine. Carcinogenesis 18, 1505-1510
38. Wennbo, H. et al. (1997) Transgenic mice overexpressing the prolactin gene develop dramatic enlargement of the prostate gland. Endocrinology 138, 4410-4415
39. Steger, R.W. et al. (1998) Neuroendocrine and reproductive functions in male mice with targeted disruption of the prolactin gene. Endocrinology 139, 3691-3695
40. Nevalainen, M.T. et al. (1996) Expression and hormone regulation ofprolactin receptors in rat dorsal and lateral prostate. Endocrinology 137, 3078-3088
41. Nevalainen, M.T. et al. (1997) Androgen-dependent expression of prolactin in rat prostate epithelium in vivo and in organ culture. FASEB J. 11, 1297-1307
42. Stattin, P. et al. (2001) Plasma prolactin and prostate cancer risk: a prospective study. Int. J. Cancer 92, 463-465
43. Leav, I. et al. (1999) Prolactin receptor expression in the developing human prostate and in hyperplastic, dysplastic, and neoplastic lesions. Am. J. Pathol. 154, 863-870
44. Nevalainen, M.T. et al. (1997) Prolactin and prolactin receptors are expressed and functioning in human prostate. J. Clin. Invest. 99, 618-627
45. Janssen, T. et al. (1996)In vitro characterization of prolactin-induced effects on proliferation in the neoplastic LNCaP, DU145, and PC3 models of the human prostate. Cancer 77, 144-149
46. Telgmann, R. and Gellersen, B. (1998) Marker genes of decidualization: activation of the decidual prolactin gene. Hum. Reprod. Update 4, 472-479
47. Jabbour, H.N. and Critchley, H.O. (2001) Potential roles of decidual prolactin in early pregnancy. Reproduction 121, 197-205
48. Handwerger, S. and Brar, A. (2001) Human uteroplacental lactogens: physiology and molecular biology. In Prolactin (Horseman, N.D., ed.), pp. 69-188, Kluwer
49. Tseng, L. and Mazella, J. (1999) Prolactin and its receptor in human endometrium. Semin. Reprod. Endocrinol. 17, 23-27
50. Huang, J.R. et al. (1987) Regulation of prolactin production by progestin, estrogen, and relaxin in human endometrial stromal cells. Endocrinology 121, 2011-2017
51. Gregoriou, G. et al. (1999) Evaluation of serum prolactin levels in patients with endometriosis and infertility. Gynecol. Obstet. Invest. 48, 48-51
52. Brar, A.K. et al. (1999) N5 endometrial stromal cell line: a model system to study decidual prolactin gene expression. In Vitro Cell. Dev. Biol. Anim. 35, 150-154
53. Walters, C.A. et al. (1983) Human myometrium: a new potential source of prolactin. Am. J. Obstet. Gynecol. 147, 639-644
54. Bonhoff, A. and Gellersen, B. (1994) Modulation of prolactin secretion in human myometrium by cytokines. Eur. J. Obstet. Gynecol. 54, 55-62
55. Stewart, E.A. et al. (1995) The myometrium of postmenopausal women produces prolactin in response to human chronic gonadotropin and α-subunit in vitro. Fertil. Steril. 64, 972-976
56. Nowak, R.A. et al. (1993) Production of prolactin by smooth muscle cells cultured from human uterine fibroid tumors. J. Clin. Endocrinol. Metab. 76, 1308-1313
57. Nowak, R.A. et al. (1999) Prolactin is an autocrine or paracrine growth factor for human myometrial and leiomyoma cells. Gynecol. Obstet. Invest. 48, 127-132
58. O'Brien, J.M. et al. (1994) Cervicovaginal prolactin: a marker for spontaneous preterm delivery. Am. J. Obstet. Gynecol. 171, 1107-1111
59. Macfee, M.S. et al. (1987) Immunocytochemical localization of prolactin in carcinoma of the cervix. Gynecol. Oncol. 26, 314-318
60. Dorshkind, K. and Horseman, N.D. (2000) The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: insights from genetic models of hormone and hormone receptor deficiency. Endocr. Rev. 21, 292-312
61. Velkeniers, B. et al. (1998) Prolactin, growth hormone and the immune system in humans. Cell. Mol. Life Sci. 54, 1102-1108
62. Hooghe, R. et al. (1998)A role for growth hormone and prolactin in leukaemia and lymphoma? Cell. Mol. Life Sci. 54, 1095-1101
63. Kooijman, R. et al. (2000) Myeloid leukemic cells express and secrete bioactive pituitary-sized 23-kDa prolactin. J. Neuroimmunol. 110, 252-258
64. Matera, L. et al. (2000) Expression ofprolactin and prolactin receptors by non-Hodgkin's lymphoma cells. Int. J. Cancer 85, 124-130
65. Pellegrini, I. et al. (1992) Expression of prolactin and its receptor in human lymphoid cells. Mol. Endocrinol. 6, 1023-1031
66. Dardenne, M. et al. (1994) Prolactin receptor expression in human hematopoietic tissues analyzed by flow cytofluorometry. Endocrinology 134, 2108-2114
67. diMattia, G.E. et al. (1988) A human B-lymphoblastoid cell line produces prolactin. Endocrinology 122, 2508-2517
68. Matera, L. et al. (1997) Prolactin is an autocrine growth factor for the Jurkat human T-leukemic cell line. J. Neuroimmunol. 79, 12-21
69. Matera, L. (1996) Endocrine, paracrine and autocrine actions of prolactin on immune cells. Life Sci. 59, 599-614
70. Ormandy, C.J. et al. (1997) Coexpression and cross-regulation of the prolactin receptor and sex steroid hormone receptors in breast cancer. J. Clin. Endocrinol. Metab. 82, 3692-3699
71. Melck, D. et al. (2000) Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition ofhuman breast and prostate cancer cell proliferation. Endocrinology 141, 118-126